De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
J. B. Chemicals & Pharmaceuticals Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
J. B. Chemicals & Pharmaceuticals heeft een totaal eigen vermogen van ₹29.2B en een totale schuld van ₹3.8B, wat de schuld-eigenvermogensverhouding op 12.9% brengt. De totale activa en totale passiva bedragen respectievelijk ₹39.9B en ₹10.7B. De EBIT J. B. Chemicals & Pharmaceuticals is ₹7.9B waardoor de rentedekking 24.2 is. Het heeft contanten en kortetermijnbeleggingen van ₹4.6B.
Belangrijke informatie
12.9%
Verhouding schuld/eigen vermogen
₹3.78b
Schuld
| Rente dekkingsratio | 24.2x |
| Contant | ₹4.60b |
| Aandelen | ₹29.23b |
| Totaal verplichtingen | ₹10.71b |
| Totaal activa | ₹39.94b |
Recente financiële gezondheidsupdates
These 4 Measures Indicate That J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Using Debt Reasonably Well
Jun 28
We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt
Nov 29Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?
Dec 03J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly
Aug 03Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?
Mar 29Recent updates
J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) Business Is Yet to Catch Up With Its Share Price
Sep 24Most Shareholders Will Probably Agree With J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) CEO Compensation
Aug 15J. B. Chemicals & Pharmaceuticals Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Aug 11These 4 Measures Indicate That J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Using Debt Reasonably Well
Jun 28J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar
Apr 19J. B. Chemicals & Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models
Feb 09J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar
Dec 22We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt
Nov 29J. B. Chemicals & Pharmaceuticals' (NSE:JBCHEPHARM) Dividend Will Be Increased To ₹9.25
Aug 03J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Due To Pay A Dividend Of ₹8.50
Feb 11Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?
Dec 03A Look At The Intrinsic Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
Sep 21J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly
Aug 03Estimating The Fair Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
Jun 15Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?
Mar 29J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Has Re-Affirmed Its Dividend Of ₹8.50
Feb 16With EPS Growth And More, J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Interesting
Jan 27Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( ₹18.5B ) JBCHEPHARM } overtreffen de korte termijn passiva ( ₹8.7B ).
Langlopende schulden: De kortetermijnactiva JBCHEPHARM ( ₹18.5B ) overtreffen de langetermijnschulden ( ₹2.0B ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: JBCHEPHARM heeft meer geld in kas dan de totale schuld.
Schuld verminderen: De schuld/eigen vermogen-ratio van JBCHEPHARM is de afgelopen 5 jaar gestegen van 1.7% naar 12.9%.
Schuldendekking: De schuld van JBCHEPHARM wordt goed gedekt door de operationele kasstroom ( 208.9% ).
Rentedekking: De rentebetalingen op de schuld van JBCHEPHARM worden goed gedekt door EBIT ( 24.2 x dekking).